Skip to content

    Women's Health

    Font Size
    A
    A
    A

    Antibiotic May Prevent Traveler's Diarrhea

    One Pill per Day May Keep Montezuma's Revenge Away
    By
    WebMD Health News

    Editor's note: On May 26, 2004, the FDA approved the antibiotic rifaximin, brand name Xifaxan, for the treatment of traveler's diarrhea.

    May 19, 2004 -- A new antibiotic may safely prevent traveler's diarrhea without promoting antibiotic resistance, according to a new study.

    Researchers say that taking an antibiotic to prevent traveler's diarrhea has been discouraged in the past because it could encourage the development of bacteria that are resistant to the antibiotic. This is an emerging problem that is making a growing number of antibiotics ineffective against common bacterial infections.

    But new research suggests an experimental antibiotic called rifaximin that stays in the gut and is not readily absorbed by the rest of the body may be effective in preventing traveler's diarrhea without encouraging antibiotic resistance.

    "The characteristics of rifaximin -- it is non-systemic since it stays in the intestine after taking it by mouth and has been shown to be 'gut-selective' in clinical trials -- make it an ideal drug for prevention of diarrhea in international travelers," says researcher Herbert L. DuPont, MD, chief of internal medicine at St. Luke's Episcopal Hospital in Houston, in a news release. "It's particularly practical in that it was effective in preventing illness with as little as one dose a day."

    Researchers say traveler's diarrhea, also known as Montezuma's revenge, affects up to 60% of international travelers and is particularly common among foreign visitors to Mexico, Latin America, Africa, and southern Asia. The illness often causes short-term diarrhea and stomach pain but can also lead to long-lasting diarrhea or irritable bowel syndrome.

    Stopping Diarrhea Before It Starts

    The antibiotic rifaximin is under consideration for approval by the FDA and is expected to be marketed under the commercial name Xifaxan after approval.

    Rifaximin has been used in other countries for the prevention of diarrhea since 1987 and is currently approved for use in 17 countries worldwide.

    In the study, presented this week at a meeting of digestive disease experts, researchers compared the effects of preventive treatment with the drug vs. placebo in a group of about 200 U.S. college students who traveled to Guadalajara, Mexico.

    Today on WebMD

    hands on abdomen
    Test your knowledge.
    womans hand on abdomen
    Are you ready for baby?
     
    birth control pills
    Learn about your options.
    insomnia
    Is it menopause or something else?
     
    woman in bathtub
    Slideshow
    period
    VIDEO
     
    bp app on smartwatch and phone
    Slideshow
    estrogen gene
    Quiz
     

    Send yourself a link to download the app.

    Loading ...

    Please wait...

    This feature is temporarily unavailable. Please try again later.

    Thanks!

    Now check your email account on your mobile phone to download your new app.

    Blood pressure check
    Slideshow
    hot water bottle on stomach
    Quiz
     
    question
    Assessment
    Attractive young woman standing in front of mirror
    Quiz